Perinatal HIV transmission
Executive Summary
FDA's Antiviral Drugs Advisory Committee will meet Oct. 4 to address issues related to the potential applicability of information from non-U.S. studies of prevention of perinatal HIV transmission to U.S. clinical settings. The meeting will begin at 8 a.m. at the Holiday Inn in Gaithersburg, Md